47 medicines lose their last listed patent or exclusivity in 2027.
January5 medicines
February3 medicines
March3 medicines
April4 medicines
May5 medicines
- Lyrica CRpregabalin · Upjohn US 2 LLC
- Rapivabperamivir · Biocryst Pharmaceuticals Inc
- Aveedtestosterone undecanoate · Endo Operations Ltd
- Janumet XRmetformin hydrochloride and sitagliptin phosphate · Merck Sharp and Dohme LLC a sub of Merck and Co Inc
- Januviasitagliptin phosphate · Merck Sharp and Dohme LLC
June5 medicines
July2 medicines
August5 medicines
- Suprep Bowel Prep Kitmagnesium sulfate, potassium sulfate and sodium sulfate · Azurity Pharmaceuticals Inc
- Lampitnifurtimox · Bayer Healthcare Pharmaceuticals Inc
- Protonix IVpantoprazole sodium · Wyeth Pharmaceuticals LLC
- Vistogarduridine triacetate · BTG International Inc
- Azilectrasagiline mesylate · Teva Neuroscience Inc
September2 medicines
October5 medicines
November1 medicine
December7 medicines
- Toviazfesoterodine fumarate · Pfizer Inc
- Valcytevalganciclovir hydrochloride · Cheplapharm Arzneimittel GmbH
- Incruse Elliptaumeclidinium bromide · Glaxo Group Ltd England dba Glaxosmithkline
- Oraceadoxycycline · Galderma Laboratories LP
- Lastacaftalcaftadine · Abbvie Inc
- Cardenenicardipine hydrochloride · Chiesi USA Inc
- Tracleerbosentan · Actelion Pharmaceuticals US Inc